Jeffrey A. Schwaneke - Nov 29, 2023 Form 4 Insider Report for agilon health, inc. (AGL)

Role
Director
Signature
/s/ Steve Meetre, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Nov 29, 2023
Transactions value $
$250,206
Form type
4
Date filed
11/30/2023, 05:04 PM
Previous filing
Apr 18, 2023
Next filing
May 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Purchase $250K +22.3K +231.54% $11.22 31.9K Nov 29, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $11.12 to $11.30, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
F2 Includes restricted stock units.